The potential use of human embryonic stem cells (hESCs) in cell-based therapies points out the critical importance of epigenomic evaluation for cell-based therapies. Specifically, DNA methylation appears to be a crucial player in establishing cell fate commitment and lineage choices. In this study, we report the global changes observed on the CpG islands distributed in promoters, gene bodies, and intergenic regions and the major biochemical pathways and genes involved in methylation changes as H9-hESCs turn into a neuronal culture containing medium-sized spiny striatal neurons (MSNs). Using an ontogeny-recapitulating protocol of striatal neuron differentiation, we analyzed DNA methylation profiles during the conversion from pluripotency to neuropotency up to the acquisition of a mature neuronal phenotype. H9-hESCs changed the methylation pattern both through de novo methylation and hypomethylation of specific gene promoters. Bioinformatic analysis allowed us to identify a panel of striatal-associated genes, which were regulated by DNA methylation and differentially expressed during striatal commitment. Importantly, DNA methylation analysis revealed that H9-hESCs did not acquire methylation-based oncogenic properties after differentiation. Indeed, hypermethylation of cancer-associated genes that characterize transformed cells, such as Polycomb repressive complex-associated genes, was not detected in the neuronal cultures. However, the oncosuppressor gene, BCL2L11, became hypermethylated in H9-hESC-derived mature neurons. Whole-genome DNA methylation profiling could become a technological platform to predict the differentiative potential of hESC-derived cultures and establish further biosafety assessment quality control tools of the cell-based products.
Get full access to this article
View all access options for this article.
References
1.
KarS, ParbinS, DebM, ShilpiA, SenguptaD, RathSK, RakshitM, PatraA and PatraSK. (2014). Epigenetic choreography of stem cells: the DNA demethylation episode of development. Cell Mol Life Sci, 71:1017–1032.
2.
LiM, LiuGH and Izpisua BelmonteJC. (2012). Navigating the epigenetic landscape of pluripotent stem cells. Nat Rev Mol Cell Biol, 13:524–535.
3.
HawkinsRD, HonGC, LeeLK, NgoQ, ListerR, PelizzolaM, EdsallLE, KuanS, LuuY, et al. (2010). Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell, 6:479–491.
4.
BirdA. (2002). DNA methylation patterns and epigenetic memory. Genes Dev, 16:6–21.
5.
WuCt and MorrisJR. (2001). Genes, genetics, and epigenetics: a correspondence. Science, 293:1103–1105.
6.
NorrisDP, BrockdorffN and RastanS. (1991). Methylation status of CpG-rich islands on active and inactive mouse X chromosomes. Mamm Genome, 1:78–83.
7.
EdwardsCA and Ferguson-SmithAC. (2007). Mechanisms regulating imprinted genes in clusters. Curr Opin Cell Biol, 19:281–289.
8.
BirdA, TaggartM, FrommerM, MillerOJ and MacleodD. (1985). A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell, 40:91–99.
9.
SaxonovS, BergP and BrutlagDL. (2006). A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A, 103:1412–1417.
10.
SongF, SmithJF, KimuraMT, MorrowAD, MatsuyamaT, NagaseH and HeldWA. (2005). Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci U S A, 102:3336–3341.
11.
OkanoM, BellDW, HaberDA and LiE. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99:247–257.
12.
LiE, BestorTH and JaenischR. (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69:915–926.
13.
TsumuraA, HayakawaT, KumakiY, TakebayashiS, SakaueM, MatsuokaC, ShimotohnoK, IshikawaF, LiE, et al. (2006). Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells, 11:805–814.
14.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS and JonesJM. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
15.
PanG and ThomsonJA. (2007). Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res, 17:42–49.
16.
BibikovaM, LaurentLC, RenB, LoringJF and FanJB. (2008). Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell, 2:123–134.
17.
MeissnerA, MikkelsenTS, GuH, WernigM, HannaJ, SivachenkoA, ZhangX, BernsteinBE, NusbaumC, et al. (2008). Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature, 454:766–770.
18.
SennerCE. (2011). The role of DNA methylation in mammalian development. Reprod Biomed Online, 22:529–535.
19.
XieW, SchultzMD, ListerR, HouZ, RajagopalN, RayP, WhitakerJW, TianS, HawkinsRD, et al. (2013). Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell, 153:1134–1148.
20.
TompkinsJD, HallC, ChenVC, LiAX, WuX, HsuD, CoutureLA and RiggsAD. (2012). Epigenetic stability, adaptability, and reversibility in human embryonic stem cells. Proc Natl Acad Sci U S A, 109:12544–12549.
21.
CalvaneseV, HorrilloA, HmadchaA, Suarez-AlvarezB, FernandezAF, LaraE, CasadoS, MenendezP, BuenoC, et al. (2008). Cancer genes hypermethylated in human embryonic stem cells. PLoS One, 3:e3294.
BaronchelliS, BentivegnaA, RedaelliS, RivaG, ButtaV, PaolettaL, IsimbaldiG, MiozzoM, TabanoS, et al. (2013). Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines. PLoS One, 8:e57462.
24.
ListerR, PelizzolaM, DowenRH, HawkinsRD, HonG, Tonti-FilippiniJ, NeryJR, LeeL, YeZ, et al. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 462:315–322.
25.
LaurentL, WongE, LiG, HuynhT, TsirigosA, OngCT, LowHM, Kin SungKW, RigoutsosI, LoringJ and WeiCL. (2010). Dynamic changes in the human methylome during differentiation. Genome Res, 20:320–331.
26.
MohnF, WeberM, RebhanM, RoloffTC, RichterJ, StadlerMB, BibelM and SchübelerD. (2008). Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell, 30:755–766.
27.
DowenRH, PelizzolaM, SchmitzRJ, ListerR, DowenJM, NeryJR, DixonJE and EckerJR. (2012). Widespread dynamic DNA methylation in response to biotic stress. Proc Natl Acad Sci U S A, 109:E2183–E2191.
28.
StraussmanR, NejmanD, RobertsD, SteinfeldI, BlumB, BenvenistyN, SimonI, YakhiniZ and CedarH. (2009). Developmental programming of CpG island methylation profiles in the human genome. Nat Struct Mol Biol, 16:564–571.
29.
ZellerC, DaiW, SteeleNL, SiddiqA, WalleyAJ, Wilhelm-BenartziCS, RizzoS, van der ZeeA, PlumbJA and BrownR. (2012). Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling. Oncogene, 31:4567–4576.
30.
GiffordCA, ZillerMJ, GuH, TrapnellC, DonagheyJ, TsankovA, ShalekAK, KelleyDR, ShishkinAA, et al. (2013). Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell, 153:1149–1163.
31.
BerdascoM, MelguizoC, PradosJ, GómezA, AlaminosM, PujanaMA, LopezM, SetienF, OrtizR, et al. (2012). DNA methylation plasticity of human adipose-derived stem cells in lineage commitment. Am J Pathol, 181:2079–2093.
32.
GuilleminC, ProvençalN, SudermanM, CôtéSM, VitaroF, HallettM, TremblayRE and SzyfM. (2014). DNA methylation signature of childhood chronic physical aggression in T cells of both men and women. PLoS One, 9:e86822.
33.
BeissbarthT and SpeedTP. (2004). GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics, 20:1464–1465.
34.
SupekF, BošnjakM, ŠkuncaN and ŠmucT. (2011). REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One, 6:e21800.
35.
WeinsteinJN, MyersTG, O'ConnorPM, FriendSH, FornaceAJ, KohnKW, FojoT, BatesSE, RubinsteinLV, et al. (1997). An information-intensive approach to the molecular pharmacology of cancer. Science, 275:343–349.
36.
ZhangB, KirovS and SnoddyJ. (2005). WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res, 33:W741–W748.
37.
HulsenT, de VliegJ and AlkemaW. (2008). BioVenn—a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics, 9:488.
38.
OnoratiM, CastiglioniV, BiasciD, CesanaE, MenonR, VuonoR, TalpoF, GoyaRL, LyonsPA, et al. (2014). Molecular and functional definition of the developing human striatum. Nat Neurosci, 17:1804–1815.
39.
WeberM, HellmannI, StadlerMB, RamosL, PääboS, RebhanM and SchübelerD. (2007). Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet, 39:457–466.
40.
NissenbaumJ, Bar-NurO, Ben-DavidE and BenvenistyN. (2013). Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells. Stem Cell Reports, 1:509–517.
41.
LeeTI, JennerRG, BoyerLA, GuentherMG, LevineSS, KumarRM, ChevalierB, JohnstoneSE, ColeMF, et al. (2006). Control of developmental regulators by Polycomb in human embryonic stem cells. Cell, 125:301–313.
42.
ReikW. (2007). Stability and flexibility of epigenetic gene regulation in mammalian development. Nature, 447:425–432.
43.
BerdascoM and EstellerM. (2011). DNA methylation in stem cell renewal and multipotency. Stem Cell Res Ther, 2:42.
44.
NazorKL, AltunG, LynchC, TranH, HarnessJV, SlavinI, GaritaonandiaI, MüllerFJ, WangYC, et al. (2012). Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell, 10:620–634.
45.
BrunnerAL, JohnsonDS, KimSW, ValouevA, ReddyTE, NeffNF, AntonE, MedinaC, NguyenL, et al. (2009). Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res, 19:1044–1056.
46.
NgJH, HengJC, LohYH and NgHH. (2008). Transcriptional and epigenetic regulations of embryonic stem cells. Mutat Res, 647:52–58.
47.
FarthingCR, FiczG, NgRK, ChanCF, AndrewsS, DeanW, HembergerM and ReikW. (2008). Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genet, 4:e1000116.
48.
BockC, BeermanI, LienWH, SmithZD, GuH, BoyleP, GnirkeA, FuchsE, RossiDJ and MeissnerA. (2012). DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol Cell, 47:633–647.
49.
EhrlichM and LaceyM. (2013). DNA methylation and differentiation: silencing, upregulation and modulation of gene expression. Epigenomics, 5:553–568.
50.
SheafferKL, KimR, AokiR, ElliottEN, SchugJ, BurgerL, SchübelerD and KaestnerKH. (2014). DNA methylation is required for the control of stem cell differentiation in the small intestine. Genes Dev, 28:652–664.
51.
HongSJ, KangMI, OhJH, JungYC, KimYH, KimSJ, ChoiSH, SeoEJ, ChoiSW and RhyuMG. (2009). DNA methylation and expression patterns of key tissue-specific genes in adult stem cells and stomach tissues. J Korean Med Sci, 24:918–929.
52.
ThurmanRE, RynesE, HumbertR, VierstraJ, MauranoMT, HaugenE, SheffieldNC, StergachisAB, WangH, et al. (2012). The accessible chromatin landscape of the human genome. Nature, 489:75–82.
53.
BenderA and WeberM. (2013). DNA methylation: an identity card for brain cells. Genome Biol, 14:131.
54.
MartinDM, SkidmoreJM, FoxSE, GagePJ and CamperSA. (2002). Pitx2 distinguishes subtypes of terminally differentiated neurons in the developing mouse neuroepithelium. Dev Biol, 252:84–99.
55.
FreedWJ, ChenJ, BäckmanCM, SchwartzCM, VazinT, CaiJ, SpivakCE, LupicaCR, RaoMS and ZengX. (2008). Gene expression profile of neuronal progenitor cells derived from hESCs: activation of chromosome 11p15.5 and comparison to human dopaminergic neurons. PLoS One, 3:e1422.
56.
WaiteMR and MartinDM. (2015). Axial level-specific regulation of neuronal development: Lessons from PITX2. J Neurosci Res, 93:195–198.
57.
JainM, ArmstrongRJ, BarkerRA and RosserAE. (2001). Cellular and molecular aspects of striatal development. Brain Res Bull, 55:533–540.
58.
BerkeJD, PaletzkiRF, AronsonGJ, HymanSE and GerfenCR. (1998). A complex program of striatal gene expression induced by dopaminergic stimulation. J Neurosci, 18:5301–5310.
59.
SasakiT, KoteraJ and OmoriK. (2004). Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons. J Neurochem, 89:474–483.
60.
RoesslerR, SmallwoodSA, VeenvlietJV, PechlivanoglouP, PengSP, ChakrabartyK, Groot-KoerkampMJ, PasterkampRJ, WesselingE, et al. (2014). Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons. Stem Cell Reports, 2:520–533.
61.
MomčilovićO, LiuQ, SwistowskiA, Russo-TaitT, ZhaoY, RaoMS and ZengX. (2014). Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells. Stem Cells Dev, 23:406–420.
62.
SaltiA, NatR, NetoS, PuschbanZ, WenningG and DechantG. (2013). Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons. Stem Cells Dev, 22:397–411.
63.
MiyataK, MiyataT, NakabayashiK, OkamuraK, NaitoM, KawaiT, TakadaS, KatoK, MiyamotoS, HataK and AsaharaH. (2015). DNA methylation analysis of human myoblasts during in vitro myogenic differentiation: de novo methylation of promoters of muscle-related genes and its involvement in transcriptional down-regulation. Hum Mol Genet, 24:410–423.
64.
ParsonsXH. (2012). An engraftable human embryonic stem cell neuronal lineage-specific derivative retains embryonic chromatin plasticity for scale-up CNS regeneration. J Regen Med Tissue Eng, 1:3.
65.
ParsonsXH. (2013). Embedding the future of regenerative medicine into the open epigenomic landscape of pluripotent human embryonic stem cells. Annu Res Rev Biol, 3:323–349.
66.
Valk-LingbeekME, BruggemanSW and van LohuizenM. (2004). Stem cells and cancer; the polycomb connection. Cell, 118:409–418.
67.
OhmJE, McGarveyKM, YuX, ChengL, SchuebelKE, CopeL, MohammadHP, ChenW, DanielVC, et al. (2007). A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet, 39:237–242.
68.
WuX, RauchTA, ZhongX, BennettWP, LatifF, KrexD and PfeiferGP. (2010). CpG island hypermethylation in human astrocytomas. Cancer Res, 70:2718–2727.
69.
O'ConnorL, StrasserA, O'ReillyLA, HausmannG, AdamsJM, CoryS and HuangDC. (1998). Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J, 17:384–395.
70.
LeoE, ManciniM, AluigiM, CastagnettiF, MartinelliG, BarbieriE and SantucciMA. (2012). DNA hypermethylation promotes the low expression of pro-apoptotic BCL2L11 associated with BCR-ABL1 fusion gene of chronic myeloid leukaemia. Br J Haematol, 159:373–376.
71.
FernandezSV, HuangY, SniderKE, ZhouY, PogashTJ and RussoJ. (2012). Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol, 41:369–377.
HeW, KangX, DuH, SongB, LuZ, HuangY, WangD, SunX, YuY and FanY. (2014). Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray. PLoS One, 9:e108350.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
